Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

TPST

5 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in Tempest Therapeutics, Inc.

No. Qube Research & Technologies exited its TPST (Tempest Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 27 shares worth $59. Qube Research & Technologies first reported TPST in Q3 2023 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$8

Total Shares Change

-27

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$18.20
0
2024-Q2
Unchanged
27
0.0%
$590.0%$28.47
0
2024-Q1
Unchanged
27
0.0%
$1060.0%$50.83
0
2023-Q4
Unchanged
27
0.0%
$1190.0%$57.20
0
2023-Q3
New
27
-
$80.0%$3.97
17

Other major holders of TPST: FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used